Profil
Theis Kipling is currently Chief Executive Officer at Biovica International AB since 2026.
Formerly, Mr. Kipling was Chief Commercial Officer at Devyser Diagnostics AB from 2022 to 2026 and Chief Commercial Officer at Atlas Antibodies AB.
Aktive Positionen von Theis Kipling
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOVICA INTERNATIONAL AB | Vorstandsvorsitzender | 01.05.2026 |
Ehemalige bekannte Positionen von Theis Kipling
| Unternehmen | Position | Ende |
|---|---|---|
| DEVYSER DIAGNOSTICS AB | Corporate Officer/Principal | 01.05.2026 |
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Atlas Antibodies AB
Atlas Antibodies AB BiotechnologyHealth Technology Develops, produces and markets reagents for biomedical research | Health Technology |
Biovica International AB
Biovica International AB BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes blood-based biomarker assays | Health Technology |
Devyser Diagnostics AB
Devyser Diagnostics AB Medical SpecialtiesHealth Technology Manufactures and sells diagnostic kits | Health Technology |
















